Shanghai Fosun Pharmaceutical (Group) Co., Ltd. proposed ordinary final dividend of RMB 0.27 per share for the year ended 31 December 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.72 CNY | +0.13% | -2.55% | -5.23% |
May. 15 | Fosun Pharma Unit Fosun Health to Receive Capital Injection from Foshan Chanxi City Investment | MT |
May. 15 | China Approves Clinical Trials For Breast Cancer Drugs | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.23% | 7.92B | |
+31.78% | 694B | |
+29.54% | 593B | |
-1.89% | 371B | |
+19.11% | 331B | |
+6.16% | 290B | |
+14.11% | 239B | |
-3.48% | 209B | |
+9.87% | 209B | |
+8.05% | 169B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Shanghai Fosun Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023